COMPOSITION AND FORM OF RELEASE
The Purevax RCP vaccine consists of several components that are mixed at the time of use:
• a lyophilized component, which is an attenuated feline rhinotracheitis herpesvirus, inactivated feline calicivirus antigens and an attenuated feline panleukopenia virus; in appearance - a dry homogeneous mass of white color
• a liquid component - a solution for the preparation of a suspension (water for injection), in appearance - a transparent liquid.
The components of the Purevax RCP vaccine are packaged in glass vials of 1 ml (1 dose). The vials are sealed with rubber stoppers and rolled with aluminum caps. Each vial is provided with a label indicating: the name of the manufacturer and its trademark, the name and purpose of the vaccine, its volume in the vial, the route of administration, the batch number, the expiration date.

BIOLOGICAL PROPERTIES
Purevax RCP vaccine stimulates the immune response in cats against the causative agents of panleukopenia, herpesvirus and calicivirus infections in vaccinated cats. The vaccine is harmless, areactogenic, has no therapeutic properties.
Immunity is formed on the 14-21st day after administration, lasting at least 12 months.

INDICATIONS
For preventive immunization of healthy cats against panleukopenia, rhinotracheitis and calicivirus.

DOSES AND ADMINISTRATION
Only healthy animals free from helminths are vaccinated with Purevax RCP vaccine.
When vaccinating, it is necessary to observe the rules of asepsis and antisepsis and use only sterile instruments for injection.
Before vaccination, the lyophilized component of the Purevax RCP vaccine is dissolved in the liquid component. The prepared preparation must be used immediately. The Purevax RCP vaccine is administered in a dose of 1 ml subcutaneously in the shoulder blade area, regardless of the weight and breed of cats.
Primovaccination: the first injection - at the age of 8 weeks and older, the second injection - after 3-4 weeks. Revaccination - after 12 months, and then annually (once in the same doses).

CONTRAINDICATIONS
Clinically ill and weakened animals, as well as pregnant and lactating females, are not subject to vaccination.
Purevax RCP vaccine cannot be used simultaneously with other immunobiological drugs, with the exception of the rabies vaccine "Rabizin" manufactured by Merial, provided that they are administered separately. Other vaccines can be prescribed 14 days before or after the use of Purevax RCP.

STORAGE CONDITIONS
In a dry place, protected from light, inaccessible to children and animals, in the manufacturer's packaging. Separately from food and feed at a temperature of 2 °C to 8 °C. Do not allow freezing. The shelf life of the vaccine is 24 months from the date of manufacture under the specified storage conditions. Vials with broken seals, mold, mechanical impurities, and those that have been frozen are rejected and disinfected by boiling for 10 minutes.